ArticlePloS one2017

PTEN expression as a predictor for the response to trastuzumab-based therapy in Her-2 overexpressing metastatic breast cancer.

Daphne Gschwantler-Kaulich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.